In addition, the authors noted a significant elevation in SOD and CAT activity in the RBCs of MS patients after the supplementation of melatonin with WBC, but the effects cannot be attributed to either melatonin or WBC, due to the lack of a proper control group (those with only melatonin were not exposed to WBC) [61]. The gene discussed is CAT; the disease is myeloid sarcoma.